MAP2K1 and cystic fibrosis: In addition, the ability of CF neutrophils to phagocytose serum-opsonized E. coli (Figures 3A, C) or S. aureus (Figures 3B, D) pHrodo bioparticles was not impacted by addition of MEK1/2 inhibitors.